Thomas Lietman, MD

Thomas Lietman
Global Health Sciences Faculty Affiliate

Phone: 415-502-2662
UCSF Box: 0412
Email: [email protected]
UCSF Profile

Project Sponsor Location(s) Topics Start
End
AVENIR: Assessing the impact of azithromycin on child mortality in Niger Bill & Melinda Gates Foundation Niger Zoonosis, Emerging Disease, and Drug Resistance, Pharmacology and Drug Treatment, Pediatrics, Newborn and Infant Health, Health Economics and Effectiveness
Infectious and inflammatory eye disease epidemic detection and seasonality United States Eye Disease and Blindness
Planning Grant for a large scale azithromycin trial for prevention of under-5 mortality in Niger Bill & Melinda Gates Foundation Niger Malaria, Eye Disease and Blindness, Pediatrics
Quantitative analysis and modelling on targets and strategies for alleviating the burden of priority neglected tropical diseases University of Oxford Ethiopia Eye Disease and Blindness
Village Integrated Eye Workers Trial NIH Natl Eye Institute India Eye Disease and Blindness
Forecasting Trachoma Control NIH Natl Eye Institute Ethiopia Eye Disease and Blindness, Epidemiology and Surveillance, Global Strategic Information
Digital Detection of Infectious Eye Epidemics NIH Natl Eye Institute United States Eye Disease and Blindness
Tools for the Endgame: Accelerating the development and introduction of Dx to Support the London Declaration 2020 goals for Neglected Tropical Diseases (NTDs) Program for Appropriate Technology in Health (PATH) Ethiopia Neglected Tropical Diseases (NTDs), Eye Disease and Blindness
NTD (Neglected Tropical Diseases) Modelling Consortium University of Warwick United Kingdom Neglected Tropical Diseases (NTDs), Epidemiology and Surveillance
Trachoma control in Africa through mass antibiotic administration, and corneal ulcer prevention and treatment in South Asia Ethiopia; India Infectious Disease, Eye Disease and Blindness
Village Integrated Eye Workers Trial NIH Natl Eye Institute India Infectious Disease, Eye Disease and Blindness, Risk Reduction and Prevention
Mortality Reduction After Oral Azithromycin Bill & Melinda Gates Foundation Ethiopia; Niger Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Epidemiology and Surveillance
P-S RPB - Assessing Corneal Ulcer Prevention with a Community-Randomized Trial Research to Prevent Blindness, Inc. India Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
TANA II NIH National Eye Institute Ethiopia Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment, Epidemiology and Surveillance
Leveraging Core Groups -- A New Way to Protect Against Infectious Trachoma Bill & Melinda Gates Foundation Ethiopia; Tanzania; Gambia; Niger; India Infectious Disease, Eye Disease and Blindness, Epidemiology and Surveillance
Mycotic Ulcer Treatment Trial NIH National Eye Institute India Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
Research to Programs for Trachoma Elimination Johns Hopkins University Tanzania; Gambia; Niger Infectious Disease, Eye Disease and Blindness, Pharmacology and Drug Treatment, Epidemiology and Surveillance
Elimination of Infectious Trachoma from Ethiopia Using Repeated Mass Antibiotic Distributions Research to Prevent Blindness, Inc. Ethiopia Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness
Strategies for the Control and Elimination of Blinding Trachoma London School of Hygiene & Tropical Medicine Egypt Infectious Disease, Neglected Tropical Diseases (NTDs), Eye Disease and Blindness
The Steroids for Corneal Ulcers Trial NIH National Eye Institute India Infectious Disease, Eye Disease and Blindness, Pharmacology and Drug Treatment
What is the Appropriate Frequency and Duration of Mass Azithromycin International Trachoma Initiative Ethiopia Neglected Tropical Diseases (NTDs), Eye Disease and Blindness, Pharmacology and Drug Treatment
Eliminating Trachoma with Repeat Mass Drug Treatment NIH National Eye Institute Ethiopia; Niger Eye Disease and Blindness, Pharmacology and Drug Treatment
Predicting Resistance: Validating Mathematical Models NIH National Institute of Allergy and Infectious Disease Ethiopia; India Eye Disease and Blindness, Epidemiology and Surveillance